HK Vincent, KE Innes, KR Vincent - Diabetes, obesity & metabolism, 2007 - pt.wkhealth.com Results: Obesity elevates oxidative stress in young, old and clinical
populations as shown by elevations in lipid peroxidation (malondialdehyde,
hydroperoxides, 4-hydroxynonenal, isoprostanes, conjugated dienes) or ... Cited by 26 - Related articles - BL Direct - All 6 versions
AJ Bank, AS Kelly, DR Kaiser, WW Crawford, … - Vascular Medicine, 2006 - vmj.sagepub.com Current evidence suggests that erectile dysfunction (ED) may be an early marker
of atherosclerosis and sys- temic vascular disease. Cardiovascular disease (CVD)
and ED share many common risk factors such as age, hypertension, ... Cited by 18 - Related articles - All 3 versions
RA Hammoud, CS Vaccari, SH Nagamia, BV … - Vascular Health and Risk Management, 2007 - pubmedcentral.nih.gov Activation of the renin–angiotensin system (RAS) is significant in the
pathogenesis of cardiovascular disease and specifically coronary
atherosclerosis. There is strong evidence that the RAS has effects on the ... Cited by 13 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org N Tentolouris, R Nzietchueng, V Cattan, G … - Diabetes Care, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 84 men with type 2 diabetes, 40 with MA
and 44 without MA (aged 63.5 ± 9.0 vs. 61.2 ± 9.8 years), were studied. TRF
length was determined in white blood cells. MA was defined as albumin ... Cited by 9 - Related articles - BL Direct - All 4 versions
A Babu, L Fogelfeld - Disease-a-Month, 2006 - Elsevier The clustering of common conditions like hyperglycemia, hypertension, and
dyslipidemia was first brought to attention by Gerald Reaven in the Banting
lecture, 1998, 1 and was called Syndrome X or the Insulin Resistance ... Cited by 5 - Related articles - All 2 versions
S Tobe, K Kawecka-Jaszcz, F Zannad, G … - Journal of Clinical Hypertension, 2007 - interscience.wiley.com This randomized, comparative, parallel-group trial investigated strategies of
blood pressure (BP)-lowering in patients with diabetes and hypertension.
Patients not reaching goal BP (<130/80 mm Hg) after 4-week open-label ... Cited by 6 - Related articles - BL Direct - All 4 versions
SS Holcomb - Current Hypertension Reports, 2005 - Springer Introduction It is becoming increasingly recognized that earlier identifi-
cation of those at risk for the development of type 2 diabe- tes mellitus (DM2),
especially in combination with hypertension, leads to earlier treatment and ... Cited by 4 - Related articles - BL Direct - All 4 versions
S Nagamia, A Pandian, F Cheema, R … - Prev Cardiol, 2007 - interscience.wiley.com Forty-four patients with the metabolic syndrome were placed on a reduced-calorie
and reduced-fat regimen to lose weight throughout a 56-week period. The patients
were treated in a crossover fashion with placebo and the ... Cited by 4 - Related articles - All 2 versions
JWC Brock, AJ Jenkins, TJ Lyons, RL Klein, E … - The Journal of Lipid Research, 2008 - ASBMB Cardiovascular disease is a major cause of morbidity and premature mortality in
diabetes. HDL plays an important role in limiting vascular damage by removing
cholesterol and cholesteryl ester hydroperoxides from oxidized low density ... Cited by 4 - Related articles - All 3 versions
CA Böger, AK Götz, B Krüger, M Hösl, G … - Eur J Med Res, 2005 - daignet.de Abstract Introduction: The role of interaction of polymorphisms in the
Renin-Angiotensin-System (RAS) with an- giotensin converting enzyme (ACE) or
angiotensin re- ceptor (AGTR1) inhibitors (RAS inhibitors) is un- known, as ... Cited by 4 - Related articles - View as HTML - All 8 versions
